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AbstrAct
Rhabdomyolysis is the combination of symptoms 
(myalgia, weakness and muscle swelling) and 
a substantial rise in serum creatine kinase 
(CK) >50 000 IU/L; there are many causes, 
but here we specifically address exertional 
rhabdomyolysis. The consequences of this 
condition can be severe, including acute kidney 
injury and requirement for higher level care with 
organ support. Most patients have ‘physiological’ 
exertional rhabdomyolysis with no underlying 
disease; they do not need investigation 
and should be advised to return to normal 
activities in a graded fashion. Rarely, exertional 
rhabdomyolysis may be the initial presentation of 
underlying muscle disease, and we review how 
to identify this much smaller group of patients, 
who do require investigation.
cAse 1
A 25-year-old male personal trainer ran a 
‘fun run’ on a hot day wearing a heavy 
costume. He collapsed 9 km into the 
run and was brought to hospital. He was 
agitated and confused (Glasgow Coma 
Scale score 10; E3, V3, M4), feverish 
(40.5°C) and tachycardic (149 bpm) with 
muscle pain and weakness. He was cooled 
and given intravenous fluids. Investiga-
tions showed serum creatine kinase (CK) 
concentration was 3000 IU/L, rising to 
105 000 IU/L at 24 hours, with an acute 
kidney injury and myoglobinuria. He was 
discharged 3 days later with no neurolog-
ical deficit and normal renal function; his 
CK normalised after 3 weeks. He was an 
athletic man who had completed several 
marathons, with no medical conditions or 
family history of neuromuscular disease.
cAse 2
A 42-year-old male security supervisor 
attended a training course involving 
intense physical exertion. He became 
dehydrated and took oral and topical 
ibuprofen. He attended the emergency 
department 3 days afterwards with flank 
pain and dark urine. Neurological exam-
ination was normal but his serum CK was 
>300 000 IU/L and he required dialysis 
for acute kidney injury with myoglobin-
uria. He was discharged after 1 week with 
improving kidney function and CK 2750 
IU/L. Repeat blood tests after 3 months 
showed normal kidney function and CK 
334 IU/L, remaining elevated at 550 IU/L 
at 1 year. He had developed exercise 
intolerance in his teenage years without 
seeking medical attention. Further inqui-
ries revealed his sister, with whom he 
had little contact for many years, had 
been diagnosed with McArdle’s disease 
in childhood. Subsequent gene testing 
demonstrated he was homozygous for 
the c.148C>T (p.Arg50Ter) pathogenic 
mutation in myophosphorylase (PGYM).
Defining rhAbDomyolysis
There is no universally agreed clinical defi-
nition of rhabdomyolysis, but a working 
definition would encompass the twin 
features of symptomatic muscle involve-
ment and a substantial rise in serum CK, 
usually >50 000 IU/L. Muscle symp-
toms include myalgia, weakness and/or 
swelling. The presence of myoglobinuria 
is not required and many laboratories do 
not routinely measure serum and urinary 
myoglobin. Nevertheless, patients should 
be asked about changes in urine color-
ation, which may be the classical ‘Coca-
Cola’ of myoglobinuria. Urine should 
be dipstick tested: haemoglobin without 
erythrocytes indicates myoglobinuria.
cAuses of rhAbDomyolysis
Rhabdomyolysis can be divided into 
non-exertional and exertional causes 
(box 1), although certain non-exertional 
causes are due to generalised muscle over-
activity, such as alcohol withdrawal, status 
epilepticus or tetany. Some causes, such as 
statin medications, may be obvious but 
others need more careful thought, as in 
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Table 1 Exercise-associated heat illnesses
Heat cramps Exercise-associated muscle cramps are a mild form of exertional heat illness familiar to those who watch sports (except 
perhaps for darts aficionados) characterised by severe muscle pain and spasms/prolonged muscle contraction without other 
features.
Heat syncope Exercise-associated transient loss of consciousness usually occurs after exercise cessation. The likely cause is a sudden 
reduction in venous return secondary to reduced skeletal muscle tone, and diversion of blood flow to extremities to lose heat. 
Recovery is rapid and complete (as in vasovagal syncope) and core body temperature is not elevated.
Heat exhaustion Characterised by difficulty continuing with exercise with raised core body temperature but no significant or prolonged 
alteration of mental state.
Heat stroke Combination of elevated core temperatures (above 40°C) and altered mental state. Other end organs may also be damaged, 
including muscles (raised serum CK), kidneys (acute kidney injury) and liver (elevated liver enzymes).
Heat injury A description used by military physicians (but not recognised in ICD-10) to describe heat exhaustion and end-organ damage 
without mental state changes.
CK, creatine kinase; ICD-10, International Classification of Diseases, 10th Revision.
Box 1 Causes of rhabdomyolysis
Non-exertional causes
 ► Drug
 – Amphetamines, cocaine, cyclosporine, fibrates, 
isoniazid, lithium, neuromuscular blocking agents, 
propofol, quetiapine, statins, zidovudine.
 ► Toxic
 – Alcohol, heavy metal poisoning, snake venom.
 ► Metabolic
 – Alcohol withdrawal, electrolyte abnormalities, 
hypothyroidism, serotonin syndrome, status 
epilepticus.
 ► Inflammatory
 – Dermatomyositis, polymyositis.
 ► Infection
 – Coxsackie, Epstein-Barr virus, influenza, HIV, 
malaria, tetanus, other viruses.
 ► Local muscle damage
 – Crush injury, compartment syndrome, muscle 
ischaemia.
Exertional causes
 ► Heat-related injuries (table 1, case 1)
 – Heat stroke, heat injury.
 ► Metabolic myopathies
 – Glycogenolytic disorders.
 – Fatty acid metabolism disorders.
 – Mitochondrial disorders.
 – Structural myopathies (eg, dystrophinopathies).
activity is required, particularly for certain metabolic 
myopathies where events can be triggered by non-ex-
ertional muscle contraction, including emotional 
situations.1
exercise-inDuceD rhAbDomyolysis
Exertional rhabdomyolysis is the combination of 
muscle symptoms (myalgia, weakness and swelling) 
and a substantial rise in serum CK (>50 000 IU/L) in 
the setting of exercise. Serum CK rises after exercise 
are common and are asymptomatic in up to half of 
cases.2 Mean serum CK values 24 hours after mara-
thons are 3322 IU/L for men (22× baseline) and 946 
IU/L for women (9× baseline).3 The clinical signifi-
cance of the serum CK concentration is unclear: 6000 
IU/L has been cited as the minimum necessary for 
renal failure4 but case reports indicate acute kidney 
injury may occur with a serum CK of 5000 IU/L5 and 
other studies suggest no safe serum concentration of 
CK.6 Pragmatically, a rise in CK to >5000 U/L and/
or evidence of end-organ damage (eg, myoglobin-
uria or decline in renal/liver function) is sufficient 
for a diagnosis of exertional rhabdomyolysis. Patients 
with exertional rhabdomyolysis may also experience 
fever, nausea and decreased/absent urine production. 
Supportive biochemical findings include hyperka-
laemia, hyponatraemia, hyperphosphataemia, hyper-
calcaemia or hypocalcaemia and metabolic acidosis.
Most cases of exertional rhabdomyolysis are caused 
by heat-related injuries, specifically heat stroke and 
heat injury. The WHO’s International Classification 
of Diseases, 10th Revision includes four overlap-
ping categories relating to exertional heat conditions 
(table 1). These symptoms are worth enquiring about 
since rhabdomyolysis in the context of a clear-cut 
heat-related condition usually does not require further 
investigation.
consequences of exertionAl 
rhAbDomyolysis
Exertional rhabdomyolysis causes traumatic and meta-
bolic damage to myocytes, resulting in local muscle 
injury and systemic effects from release of intracel-
lular contents. Acute kidney injury from myoglobin 
toxicity is a feared complication, but other serious 
consequences include compartment syndrome, hyper-
kalaemia and disseminated intravascular coagulation. 
Patients with preceding heat exposure may experience 
altered mental state, probably hyperthermia induced, 
which may be ameliorated by adequate hydration.7 The 
consequences of untreated exertional rhabdomyolysis  on
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Box 2 Features suggesting need for further 
investigation18
R—Recurrent episodes of exertional rhabdomyolysis
H—HyperCKaemia more than 8 weeks after event
A—Accustomed to exercise
B—Blood creatine kinase (CK) concentration above 50× 
upper limit of normal
D—Drug ingestion insufficient to explain exertional rhab-
domyolysis
O—Other family members affected or Other exertional 
symptoms
figure 1 A suggested approach to investigating exertional rhabdomyolysis. CK, creatine kinase.
are described in the earliest account of this condition, 
from the Roman invasion of southern Arabia in 24 BC 
led by Aelius Gallus:
The desert, the sun, and the water … caused his men 
great distress, so that the larger part of the army 
perished. The malady … attacked the head and caused 
it to become parched, killing forthwith most of those 
who were attacked, but in the case of those who 
survived this stage it descended to the legs, skipping 
all the intervening parts of the body, and caused dire 
injury to them.
Dio Cassus (150–235 AD)8
Rates of renal failure after exertional rhabdomyolysis 
vary between studies, in keeping with uncertain diag-
nostic criteria for both acute kidney injury and exer-
tional rhabdomyolysis. A study of 1203 US Army 
soldiers with exertional rhabdomyolysis found that 8% 
developed renal failure9; a civilian case series of 475 
patients with rhabdomyolysis reported 46% had acute 
kidney injury.10 A Danish study of 161 rhabdomyolysis 
cases found 27% were exercise induced, mostly from 
weight training rather than endurance exercise; none 
had significant acute kidney injury.11 There appears 
to be a rising incidence of exertional rhabdomyolysis, 
perhaps related to societal changes in exercise prefer-
ence12; ‘rhabdo’ is now well recognised among exer-
cise enthusiasts and articles have appeared in the lay 
press in recent years with the advent of high-intensity 
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Table 2 Summary of inherited metabolic causes of exertional rhabdomyolysis
Metabolic pathway Trigger Baseline CK
Baseline 
weakness Examples
Glycogen metabolism Early onset after intense 
exercise
Often high May develop in 
later life
 ► McArdle’s disease (second wind phenomenon)
 ► Tarui’s syndrome (↑exercise tolerance when fasting, 
compensated haemolysis)
 ► Lactate dehydrogenase-A deficiency (photosensitive 
rash)
Fatty acid metabolism Later onset after prolonged 
exercise or illness/fasting
Normal Unusual  ► Carnitine palmitoyltransferase (diffuse exertional 
weakness, respiratory failure)
Mitochondrial metabolism Early or late onset, prominent 
fatigue
Normal or high Possible  ► Coenzyme Q10 (encephalopathy, ataxia, 
convulsions)
 ► Cytochrome B/C (onset after mild exercise)
CK, creatine kinase.
outcome in these cases is good, with little evidence of 
permanent renal dysfunction.6
The psychological impact of a major health event 
on an otherwise well person should not be neglected. 
The patient in case 1 found the experience sufficiently 
traumatic that he could not exercise, having to change 
career.
inciDence AnD risk fActors for exertionAl 
rhAbDomyolysis
It is challenging to define the incidence of exertional 
rhabdomyolysis since many patients do not present 
to medical attention. The US Army study suggested 
an annual incidence of 7/10 000, although in a 
highly selected group.9 Risk factors for greater rises 
in serum CK after exercise include low premorbid 
physical fitness, male sex, African ethnicity, dehy-
dration and high-intensity prolonged weight-bearing 
exercises, particularly eccentric muscle contractions 
(muscle contraction during muscle lengthening, eg, 
downhill running).14 Any impairment of heat loss 
increases the risk of exertional rhabdomyolysis, 
including environmental factors (higher ambient 
temperatures, clothing) and use of vasoconstric-
tive drugs (amphetamines). Non-steroidal anti-in-
flammatory medications do not increase the risk of 
exertional rhabdomyolysis but permit exercise to 
continue beyond normal limits and so increase the 
risk of acute kidney injury (case 2).
The risk of exertional rhabdomyolysis is increased 
up to 11-fold in those with previous heat injuries and 
over 50% of patients with exertional rhabdomyolysis 
have a history of heat cramps or heat exhaustion.9 
Sickle-cell trait increases risk with HR 1.54 (95% 
CI 1.12 to 2.12)15; fatal exertional rhabdomyolysis 
has also occurred in athletes with sickle-cell trait.16 
Other risk factors include obesity (HR 1.39, 95% CI 
1.04 to 1.86), tobacco smoking (HR 1.54, 95% CI 
1.23 to 1.94), antipsychotic medications (HR 3.02, 
95% CI 1.34 to 6.82) and statins (HR 2.89, 95% 
CI 1.51 to 5.55).15 The colloquial farming term of 
‘Monday morning disease’ derives from the higher 
risk of exertional rhabdomyolysis after prolonged 
rest or carbohydrate-rich diets in horses, though 
this is likely secondary to an underlying metabolic 
myopathy.17
Acute treAtment of exertionAl 
rhAbDomyolysis
The management of exertional rhabdomyolysis 
depends on the clinical presentation, with extensive 
coverage of treatment options beyond the scope of 
this article. Clinicians should have a low threshold 
for referral to the intensive care unit, particularly 
where the serum CK concentration is >10 000 U/L, 
the patient needs active cooling, or there is end-organ 
dysfunction such as obtundation.18 Giving high-
volume intravenous fluids early, aiming for urine 
outputs of above 200 mL/hour, seems beneficial19; 
serum electrolytes should be checked frequently. 
Urinary alkalinisation improves myoglobin removal, 
though there is no evidence that sodium bicar-
bonate or mannitol helps.5 Plasma exchange—but 
not haemodialysis— removes myoglobin. Compart-
ment syndrome requires immediate referral to ortho-
paedics or plastic surgery. All potentially causative 
drugs should be stopped, including statins, non-ste-
roidal anti-inflammatory drugs, selective serotonin 
reuptake inhibitors, supplements (weight loss treat-
ments or creatinine), recreational drugs and others.20
After discharge, the serum CK and renal function 
should be monitored every 72 hours; the CK or creat-
inine may not peak until after day 4.14 Monitoring 
can stop when the serum CK returns to below 1000 
IU/L, though its failure to return to normal concen-
tration should prompt consideration of underlying 
myopathy, as in case 2.
investigAting exertionAl rhAbDomyolysis
In general, patients with a clear history of a 
preceding heat-related illness do not require 
further investigations; this group is statistically the 
largest. Further investigations should be consid-
ered in patients with no history of heat exposure, 
or who have recurrent exertional rhabdomyolysis. 
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Key points
 ► Exertional rhabdomyolysis is potentially life 
threatening.
 ► Risk factors include unaccustomed exercise, eccentric 
exercise, sickle-cell trait, underlying genetic disorders 
and previous heat-related illnesses.
 ► Treatment involves aggressive fluid resuscitation and 
may necessitate intensive care.
 ► Patients with recurrent events, elevated baseline 
serum creatine kinase, or features consistent with 
metabolic myopathies should be considered for 
investigation for underlying genetic disorders.
 ► Rhabdomyolysis in the setting of a heat syndrome 
usually does not require further muscle investigations.
 ► Patients should return to normal activities in a graded 
fashion.
for previous milder episodes; ask about previous 
episodes of postexertional muscle pain, weakness 
or dark urine. Almost all patients with metabolic 
myopathies will have had symptoms since teenage 
years. Other features requiring further investiga-
tion include persistently raised serum CK after 8 
weeks, family history of rhabdomyolysis (including 
after exercise, fasting or illness), exertional muscle 
cramps or exercise intolerance. The acronym 
(retronym?) RHABDO has been suggested as an 
aide-mémoire (box 2).18
Clinicians should take a general myopathy history, 
including exercise intolerance, exertional rhabdo-
myolysis tempo (eg, duration between exercise and 
onset) and family history. Family history is some-
times forgotten: case 2 had little contact with his 
sister but recalled she had been diagnosed with 
something which stopped her exercising; renewed 
contact revealed her McArdle’s disease. Examina-
tion for myopathic weakness and electromyography 
should be delayed until the patient has fully recov-
ered. Further investigations for underlying causes, 
including exercise testing, muscle biopsy and muscle 
MRI, depend on the clinical phenotype but are often 
non-diagnostic until the exertional rhabdomyolysis 
has resolved. Figure 1 summarises the approach to a 
new presentation of exertional rhabdomyolysis.
A full discussion of metabolic myopathies causing 
rhabdomyolysis is beyond the scope of this article, 
but has been covered elsewhere21–23 and in table 2. 
Structural myopathies, including dystrophinopathies, 
limb-girdle muscular dystrophy 2I and dysferlinopa-
thies, can present with exertional rhabdomyolysis.22 
Many metabolic myopathies are diagnosed rela-
tively late in life, with the Spanish McArdle’s disease 
cohort having an average age of 44 years at diag-
nosis.24 This is usually due to a delay in presenta-
tion or diagnosis rather than a lack of symptoms: 
as with most metabolic myopathies, most patients 
(86%) develop symptoms in childhood (usually exer-
cise intolerance). Patients with symptom onset in 
later life are unlikely to have a metabolic myopathy, 
though subtle previous events may only be revealed 
with careful history taking.
Channelopathies, including RYR1 gene mutations 
associated with malignant hyperthermia, may cause 
exertional rhabdomyolysis.25 Rhabdomyolysis in 
patients with the RYR1 gene may be triggered by heat 
exposure without exercise, illness and alcohol. Iden-
tifying these patients is important because of the risks 
associated with administering certain anaesthetic 
agents. Other gene mutations associated with exer-
tional rhabdomyolysis include ACE, ACTN3, CCL2 
and CCR2.18 Patients with some of these mutations 
may have supranormal athletic abilities, indicating 
a trade-off between enhanced exercise aptitude and 
risk of exertional rhabdomyolysis. The presence of 
sickle-cell trait should be investigated in those with 
an appropriate ethnic background; the UK newborn 
screening programme should detect most cases.
gene pAnel
The Sheffield (UK) centre offers a rhabdomyolysis and 
metabolic myopathy 30-gene panel. The standard test 
takes 16 weeks at an NHS cost of £90026 and sequences 
the entire coding regions of 30 genes, including PYGM 
(McArdle’s disease), PFK (Tarui’s disease) and other 
glycogenolytic, fatty acid and mitochondrial metabolism 
genes; structural myopathies and channelopathies are 
not included.
role of exercise heAt tolerAnce tests
Heat tolerance testing is usually restricted to military or 
professional athletic circles. Protocols differ but consist 
of prolonged static exercise (treadmill or bicycle) in a 
controlled environment with invasive temperature moni-
toring. A ‘failed’ or positive test is where an increase in 
temperature occurs earlier, at a faster rate, and to a 
greater degree (>38.6°C), than the normal population, 
accompanied by tachycardia (>160 bpm). There is little 
evidence on the usefulness of these tests, but studies by 
the Israeli Defence Forces indicate a minimum dura-
tion of 120 min under hot (40°C) conditions.27 While 
a useful screening test in the right circumstances, exer-
cise heat tolerance tests are likely to be replaced by gene 
panel testing in many situations.
returning to normAl Activities
The risk of recurrence is low if there is no suggestion of 
an underlying genetic cause: 1%–2% suffered recurrent 
exertional rhabdomyolysis in the US Army study,9 the 
risk may be lower in the general population.
Most experts recommend a graded return to exer-
cise.18 28 Exercise should be avoided in the first month 
and until symptoms have disappeared and the serum CK 
normalised. Light exercise can then be started and grad-
ually increased in extent and duration if symptoms of 
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is best avoided, at least to start with, as is strenuous unac-
customed exercise. Patients with suspected underlying 
myopathies/genetic disorders need a stricter approach, 
as described elsewhere.18
further reADing
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